Meta-analysis of post-licensure observational studies: recombinant zoster vaccine effectiveness against herpes zoster was 80.0% in immunocompetent and 64.3% in immunocompromised adults, 73.0% after four years; heterogeneity was substantial and subgroup data limited.
Meta-analysis
Mbinta et al. Effectiveness of recombinant zoster vaccine against herpes zoster and postherpetic neuralgia: a systematic review and meta-analysis of post-licensure observational studies